Eurofarma Laboratórios S.A. Stock

Stocks

EUFA3

BREUFAACNOR4

Market Closed - Sao Paulo Other stock markets			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Latest news : Eurofarma Laboratórios S.A.

05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
21/10/25	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
21/10/25	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
22/08/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
16/05/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
27/03/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/03/25	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
15/11/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
14/08/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	23/11/2021
Alexandre Mendes Palhares IRC	Investor Relations Contact	40	23/11/2021

Director	Title	Age	Since
Marcelo Eduardo Martins BRD	Director/Board Member	58	23/11/2021
Maurízio Billi CHM	Chairman	-	23/11/2021
Cláudio Roberto Ely BRD	Director/Board Member	77	23/11/2021

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
1/10/25 A	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
12/4/24 A	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%
12/4/24 A	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 2.14B 1.88B 1.75B 1.61B 3.01B 205B 3.09B 20.79B 8.13B 101B 8.03B 7.85B 350B	12.48B 2.43B 2.14B 1.99B 1.83B 3.43B 233B 3.51B 23.64B 9.25B 115B 9.13B 8.93B 398B
Net income	117M 22.85M 20.08M 18.74M 17.2M 32.19M 2.19B 32.99M 222M 86.9M 1.08B 85.78M 83.92M 3.74B	571M 111M 97.82M 91.31M 83.8M 157M 10.66B 161M 1.08B 423M 5.28B 418M 409M 18.24B
Net Debt	-	-

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company

Income Statement and Estimates

More financial data